CKAP4 is a Dickkopf1 receptor and is involved in tumor progression

Journal of Clinical Investigation

Volumn 126, Issue 7, 2016, Pages 2689-2705

  Kimura, Hirokazu ^a   Fumoto, Katsumi ^a   Shojima, Kensaku ^a   Nojima, Satoshi ^b   Osugi, Yoshihito ^a   Tomihara, Hideo ^b   Eguchi, Hidetoshi ^b   Shintani, Yasushi ^b   Endo, Hiroko ^c   Inoue, Masahiro ^c   Doki, Yuichiro ^b   Okumura, Meinoshin ^b   Morii, Eiichi ^b   Kikuchi, Akira ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CLATHRIN; CYTOSKELETON ASSOCIATED PROTEIN 4; CYTOSKELETON ASSOCIATED PROTEIN 4 ANTIBODY; DICKKOPF 1 PROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 6; MEMBRANE PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; POLYCLONAL ANTIBODY; PROTEIN KINASE B; PROTEIN SH3; TUMOR MARKER; TUMOR PROTEIN; UNCLASSIFIED DRUG; CKAP4 PROTEIN, HUMAN; DKK1 PROTEIN, HUMAN; PROTEIN BINDING; SIGNAL PEPTIDE;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; BINDING AFFINITY; CANCER CELL; CANCER PROGNOSIS; CANCER SURVIVAL; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATIONAL STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; EXPERIMENTAL NEOPLASM; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERNALIZATION; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; OVERALL SURVIVAL; PRIORITY JOURNAL; PROLINE RICH PROTEIN DOMAIN; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RECURRENCE FREE SURVIVAL; SIGNAL TRANSDUCTION; TUMOR GROWTH; TUMOR XENOGRAFT; ANIMAL; BAGG ALBINO MOUSE; CANCER TRANSPLANTATION; CELL LINE; DOG; GENE EXPRESSION REGULATION; HEP-G2 CELL LINE; LUNG TUMOR; METABOLISM; MIDDLE AGED; NUDE MOUSE; PANCREAS TUMOR; PROTEIN DOMAIN; TUMOR CELL LINE; TUMOR RECURRENCE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; CELL LINE; CELL LINE, TUMOR; CELL PROLIFERATION; DOGS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEP G2 CELLS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LUNG NEOPLASMS; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MICE, NUDE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM TRANSPLANTATION; PANCREATIC NEOPLASMS; PROTEIN BINDING; PROTEIN DOMAINS; SIGNAL TRANSDUCTION;

EID: 84978372617     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI84658     Document Type: Article

References (53)

1. Glinka A, Wu W, Delius H, Monaghan AP, Blumenstock C, Niehrs C. Dickkopf-1 is a member of a new family of secreted proteins and functions in head induction. Nature. 1998; 391 (6665):357-362.
2. Niehrs C. Function and biological roles of the Dickkopf family of Wnt modulators. Oncogene. 2006; 25 (57):7469-7481.
3. Kikuchi A, Yamamoto H, Sato A, Matsumoto S. New insights into the mechanism of Wnt signaling pathway activation. Int Rev Cell Mol Biol. 2011; 291:21-71.
4. Clevers H, Nusse R. Wnt/β-catenin signaling and disease. Cell. 2012; 149 (6):1192-1205.
5. Mao B, et al. LDL-receptor-related protein 6 is a receptor for Dickkopf proteins. Nature. 2001; 411 (6835):321-325.
6. Semënov MV, Tamai K, Brott BK, Kühl M, Sokol S, He X. Head inducer Dickkopf-1 is a ligand for Wnt coreceptor LRP6. Curr Biol. 2001; 11 (12):951-961.
7. Brott BK, Sokol SY. Regulation of Wnt/LRP signaling by distinct domains of Dickkopf proteins. Mol Cell Biol. 2002; 22 (17):6100-6110.
8. Ahn VE, Chu ML, Choi HJ, Tran D, Abo A, Weis WI. Structural basis of Wnt signaling inhibition by Dickkopf binding to LRP5/6. Dev Cell. 2011; 21 (5):862-873.
9. Yamamoto H, Komekado H, Kikuchi A. Caveolin is necessary for Wnt-3a-dependent internalization of LRP6 and accumulation of b-catenin. Dev Cell. 2006; 11 (2):213-223.
10. Sakane H, Yamamoto H, Kikuchi A. LRP6 is internalized by Dkk1 to suppress its phosphorylation in the lipid raft and is recycled for reuse. J Cell Sci. 2010; 123 (pt 3):360-368.
11. Jiang Y, He X, Howe PH. Disabled-2 (Dab2) inhibits Wnt/β-catenin signalling by binding LRP6 and promoting its internalization through clathrin. EMBO J. 2012; 31 (10):2336-2349.
12. Demir K, et al. RAB8B is required for activity and caveolar endocytosis of LRP6. Cell Rep. 2013; 4 (6):1224-1234.
13. Yamamoto H, Sakane H, Yamamoto H, Michiue T, Kikuchi A. Wnt3a and Dkk1 regulate distinct internalization pathways of LRP6 to tune the activation of β-catenin signaling. Dev Cell. 2008; 15 (1):37-48.
14. González-Sancho JM, et al. The Wnt antagonist DICKKOPF-1 gene is a downstream target of beta-catenin/TCF and is downregulated in human colon cancer. Oncogene. 2005; 24 (6):1098-1103.
15. Niida A, et al. DKK1, a negative regulator of Wnt signaling, is a target of the β-catenin/TCF pathway. Oncogene. 2004; 23 (52):8520-8526.
16. Polakis P. The many ways of Wnt in cancer. Curr Opin Genet Dev. 2007; 17 (1):45-51.
17. Yamabuki T, et al. Dikkopf-1 as a novel serologic and prognostic biomarker for lung and esophageal carcinomas. Cancer Res. 2007; 67 (6):2517-2525.
18. Sato N, et al. Wnt inhibitor Dickkopf-1 as a target for passive cancer immunotherapy. Cancer Res. 2010; 70 (13):5326-5336.
19. Makino T, et al. Dickkopf-1 expression as a marker for predicting clinical outcome in esophageal squamous cell carcinoma. Ann Surg Oncol. 2009; 16 (7):2058-2064.
20. Shen Q, et al. Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study. Lancet Oncol. 2012; 13 (8):817-826.
21. Han SX, et al. Serum dickkopf-1 is a novel serological biomarker for the diagnosis and prognosis of pancreatic cancer. Oncotarget. 2015; 6 (23):19907-19917.
22. Pinto D, Gregorieff A, Begthel H, Clevers H. Canonical Wnt signals are essential for homeostasis of the intestinal epithelium. Genes Dev. 2003; 17 (14):1709-1713.
23. Aguilera O, et al. Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer. Oncogene. 2006; 25 (29):4116-4121.
24. Gregory CA, Singh H, Perry AS, Prockop DJ. The Wnt signaling inhibitor dickkopf-1 is required for reentry into the cell cycle of human adult stem cells from bone marrow. J Biol Chem. 2003; 278 (30):28067-28078.
25. Schweizer A, Ericsson M, Bächi T, Griffiths G, Hauri HP. Characterization of a novel 63 kDa membrane protein. Implications for the organization of the ER-to-Golgi pathway. J Cell Sci. 1993; 104 (pt 3):671-683.
26. Vedrenne C, Hauri HP. Morphogenesis of the endoplasmic reticulum: beyond active membrane expansion. Traffic. 2006; 7 (6):639-646.
27. Razzaq TM, Bass R, Vines DJ, Werner F, Whawell SA, Ellis V. Functional regulation of tissue plasminogen activator on the surface of vascular smooth muscle cells by the type-II transmembrane protein p63 (CKAP4). J Biol Chem. 2003; 278 (43):42679-42685.
28. Gupta N, Manevich Y, Kazi AS, Tao JQ, Fisher AB, Bates SR. Identification and characterization of p63 (CKAP4/ERGIC-63/CLIMP-63), a surfactant protein A binding protein, on type II pneumocytes. Am J Physiol Lung Cell Mol Physiol. 2006; 291 (3):L436-L446.
29. Conrads TP, et al. CKAP4/p63 is a receptor for the frizzled-8 protein-related antiproliferative factor from interstitial cystitis patients. J Biol Chem. 2006; 281 (49):37836-37843.
30. Yamamoto H, et al. The apical and basolateral secretion of Wnt11 and Wnt3a in polarized epithelial cells is regulated by different mechanisms. J Cell Sci. 2013; 126 (pt 13):2931-2943.
31. Yamamoto H, et al. Basolateral secretion of Wnt5a in polarized epithelial cells is required for apical lumen formation. J Cell Sci. 2015; 128 (5):1051-1063.
32. O'Brien LE, Zegers MM, Mostov KE. Opinion: Building epithelial architecture: insights from three-dimensional culture models. Nat Rev Mol Cell Biol. 2002; 3 (7):531-537.
33. Mao B, et al. Kremen proteins are Dickkopf receptors that regulate Wnt/β-catenin signalling. Nature. 2002; 417 (6889):664-667.
34. Lisanti MP, Sargiacomo M, Graeve L, Saltiel AR, Rodriguez-Boulan E. Polarized apical distribution of glycosyl-phosphatidylinositol-anchored proteins in a renal epithelial cell line. Proc Natl Acad Sci U S A. 1988; 85 (24):9557-9561.
35. Schlegel R, Dickson RB, Willingham MC, Pastan IH. Amantadine and dansylcadaverine inhibit vesicular stomatitis virus uptake and receptormediated endocytosis of a2-macroglobulin. Proc Natl Acad Sci U S A. 1982; 79 (7):2291-2295.
36. Luo J, Manning BD, Cantley LC. Targeting the PI3K-Akt pathway in human cancer: rationale and promise. Cancer Cell. 2003; 4 (4):257-262.
37. Klippel A, Escobedo JA, Hirano M, Williams LT. The interaction of small domains between the subunits of phosphatidylinositol 3-kinase determines enzyme activity. Mol Cell Biol. 1994; 14 (4):2675-2685.
38. Wymann MP, Pirola L. Structure and function of phosphoinositide 3-kinases. Biochim Biophys Acta. 1998; 1436 (1-2):127-150.
39. Yu H, Chen JK, Feng S, Dalgarno DC, Brauer AW, Schreiber SL. Structural basis for the binding of proline-rich peptides to SH3 domains. Cell. 1994; 76 (5):933-945.
40. Rickles RJ, et al. Identification of Src, Fyn, Lyn, PI3K and Abl SH3 domain ligands using phage display libraries. EMBO J. 1994; 13 (23):5598-5604.
41. Kondo J, et al. Retaining cell-cell contact enables preparation and culture of spheroids composed of pure primary cancer cells from colorectal cancer. Proc Natl Acad Sci U S A. 2011; 108 (15):6235-6240.
42. Endo H, et al. Spheroid culture of primary lung cancer cells with neuregulin 1/HER3 pathway activation. J Thorac Oncol. 2013; 8 (2):131-139.
43. Bates SR, et al. Role of P63 (CKAP4) in binding of surfactant protein-A to type II pneumocytes. Am J Physiol Lung Cell Mol Physiol. 2008; 295 (4):L658-L669.
44. Bates SR P63 (CKAP4) as an SP-A receptor: implications for surfactant turnover. Cell Physiol Biochem. 2010; 25 (1):41-54.
45. Kazi AS, Tao JQ, Feinstein SI, Zhang L, Fisher AB, Bates SR. Role of the PI3-kinase signaling pathway in trafficking of the surfactant protein A receptor P63 (CKAP4) on type II pneumocytes. Am J Physiol Lung Cell Mol Physiol. 2010; 299 (6):L794-L807.
46. Shahjee HM, Koch KR, Guo L, Zhang CO, Keay SK. Antiproliferative factor decreases Akt phosphorylation and alters gene expression via CKAP4 in T24 bladder carcinoma cells. J Exp Clin Cancer Res. 2010; 29:160.
47. Mori M, Rao SK, Popper HH, Cagle PT, Fraire AE. Atypical adenomatous hyperplasia of the lung: a probable forerunner in the development of adenocarcinoma of the lung. Mod Pathol. 2001; 14 (2):72-84.
48. Li MH, et al. Expression of cytoskeleton-associated protein 4 is related to lymphatic metastasis and indicates prognosis of intrahepatic cholangiocarcinoma patients after surgery resection. Cancer Lett. 2013; 337 (2):248-253.
49. Li SX, et al. Prognostic significance of cytoskeleton-associated membrane protein 4 and its palmitoyl acyltransferase DHHC2 in hepatocellular carcinoma. Cancer. 2014; 120 (10):1520-1531.
50. Zhang Y, et al. Canonical wnt signaling is required for pancreatic carcinogenesis. Cancer Res. 2013; 73 (15):4909-4922.
51. Fujii S, Matsumoto S, Nojima S, Morii E, Kikuchi A. Arl4c expression in colorectal and lung cancers promotes tumorigenesis and may represent a novel therapeutic target. Oncogene. 2015; 34 (37):4834-4844.
52. Shojima K, et al. Wnt5a promotes cancer cell invasion and proliferation by receptor-mediated endocytosis-dependent and-independent mechanisms, respectively. Sci Rep. 2015; 5:8042.
53. Mitsuishi Y, et al. Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming. Cancer Cell. 2012; 22 (1):66-79.